2 Minutes with Joey - BEAM Stock News

Two minutes with Joey on Beam Therapeutics (BEAM) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.

2 Minutes with Joey - BEAM Stock News is a general podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts 2 Minutes with Joey - BEAM Stock News, a general show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  2 Minutes with Joey - BEAM Stock News

  BEAM Today - Aug 06: Wider Q2 Loss Reported

  Aug 6, 20261 minS0

  Hey there! It’s Joey here, your friendly longtime investor. Let’s break down what happened with Beam Therapeutics today. So, the ticker is BEAM, and today was a red day for them. They dropped about 1.74%. Ouch!<br /><br />Now, here’s the scoop. The stock got hit after they reported a wider-than-expected loss for Q2. Revenue wasn’t looking too hot either, which had people buzzing. It seems like there’s some debate going on about their valuation. Some analysts are a bit worried about how Beam is managing its finances, while others see potential in their pipeline. It’s a mixed ba...

  ListenShow Notes
• 

  2 Minutes with Joey - BEAM Stock News

  BEAM Today - Aug 05: Earnings Miss Stings

  Aug 5, 20261 minS0

  Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while now, and today we’re talking about Beam Therapeutics, or BEAM for short. It was a bit of a rough day for them, down about 1.4%. Ouch!<br /><br />So, what went down? Beam reported their Q2 numbers today, and let’s just say they didn’t hit the mark. They brought in only $490,000 in revenue, while folks were expecting way more—like $16.4 million. Yeah, that one stung. They also posted a net loss of $122.7 million. Not exactly the news investors were hoping for.<...

  ListenShow Notes
• 

  2 Minutes with Joey - BEAM Stock News

  BEAM Today - Aug 04: Q2 Loss and Cash Plans

  Aug 4, 20262 minS0

  Hey there! It’s Joey here. I’ve been in the investing game for quite a while, and today we’re talking about Beam Therapeutics, or BEAM for short. It was a green day for them, up about 2.5%. Not too shabby!<br /><br />So, what went down? Beam reported their second-quarter earnings today, and let’s just say it was a mixed bag. They pulled in around half a million bucks in revenue, which is pretty far from what analysts were expecting. They were looking for a number closer to 16 million. Ouch! That one stung. They also reported a net loss of...

  ListenShow Notes
• 

  2 Minutes with Joey - BEAM Stock News

  BEAM Today - Aug 03: Valuation Upside Sparks Interest

  Aug 3, 20261 minS0

  Hey there! It’s Joey here, your go-to guy for stock talk. I’ve been investing for years, and today, we’re checking out Beam Therapeutics. It was a bit of a green day for BEAM, up almost a percent. Not a huge jump, but hey, green is good, right?<br /><br />So, what happened today? Well, Beam had some solid action with a nice little uptick. Nothing too crazy, but it definitely caught some eyes. The volume was pretty steady, which means folks were paying attention, and that’s always a good sign. <br /><br />Now, why did BEAM move? It...

  ListenShow Notes
• 

  2 Minutes with Joey - BEAM Stock News

  BEAM Today - Aug 02: No Major Headlines

  Aug 2, 20261 minS0

  Hey there, it’s Joey! I’ve been investing for a while now, and I’m here to break down what went down with Beam Therapeutics today. So, BEAM had a bit of a rough ride, closing down about 3.7%. Ouch.<br /><br />Now, let’s talk about what happened. Honestly, it was kind of a snooze fest today. No major headlines or news to shake things up. The stock just kinda drifted down, like a slow bleed. You know how some days you just feel the energy is off? Yeah, that was today for BEAM.<br /><br />As for the why, it’...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.